The overall goal of this U24 application is to continue supporting a team of investigators to develop new and provide established, state-of-the-art high resolution mouse imaging techniques to local cancer investigators. The Harvard Small Animal Imaging Resource (SAIR) has a proven track record for innovation in molecular imaging and clinical translation, has served over 70 regional cancer investigators and currently performs imaging studies for over 40 cancer related base grants. The Program is affiliated with two NCI designated Cancer Centers (the Dana Farber Harvard Cancer Center (DFHCC) and the MIT Center for Cancer Research) and several Mouse Model of Human Cancer Consortia (MMHCC). The specific goals of the SAIR are to: 1) increase the availability and expand types of high resolution mouse imaging systems, 2) develop new techniques and methods to image cellular and molecular information of specific cancers and organs, 3) assist with image acquisition, 4) maintain and ensure the proper use of imaging equipment, 5) assist in image analysis, processing, quantitation, interpretation and image fusion and 6) provide training to investigators and collaborators with regard to a) small animal handling and monitoring, b) small animal imaging and c) the specifics of utilizing the array of imaging equipment best to address the specific questions at hand. Ancillary cores of this Program include a Pathology, Chemistry, Cell and Bioinformatics Cores. Multidisciplinary training will involve participation in hands-on projects, seminars and didactic lecture series. The overall focus of this proposal is to provide a shared resource and tools, which allow cancer researchers to incorporate state-of-the-art imaging technologies into their individual research studies. The SAIR has become a dynamic and diverse resource wherein exchange of techniques and ideas occurs rapidly and fosters interdisciplinary collaborations in cancer research.
Gaglia, Jason L; Harisinghani, Mukesh; Aganj, Iman et al. (2015) Noninvasive mapping of pancreatic inflammation in recent-onset type-1 diabetes patients. Proc Natl Acad Sci U S A 112:2139-44 |
Robbins, Clinton S; Hilgendorf, Ingo; Weber, Georg F et al. (2013) Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med 19:1166-72 |
Feruglio, Paolo Fumene; Vinegoni, Claudio; Fexon, Lioubov et al. (2013) Noise suppressed, multifocus image fusion for enhanced intraoperative navigation. J Biophotonics 6:363-70 |
Carlson, Jonathan C T; Meimetis, Labros G; Hilderbrand, Scott A et al. (2013) BODIPY-tetrazine derivatives as superbright bioorthogonal turn-on probes. Angew Chem Int Ed Engl 52:6917-20 |
Shao, Huilin; Chung, Jaehoon; Balaj, Leonora et al. (2012) Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy. Nat Med 18:1835-40 |
Keliher, Edmund J; Reiner, Thomas; Thurber, Greg M et al. (2012) Efficient (18)F-Labeling of Synthetic Exendin-4 Analogues for Imaging Beta Cells. ChemistryOpen 1:177-183 |
Ripplinger, Crystal M; Kessinger, Chase W; Li, Chunqiang et al. (2012) Inflammation modulates murine venous thrombosis resolution in vivo: assessment by multimodal fluorescence molecular imaging. Arterioscler Thromb Vasc Biol 32:2616-24 |
Kastrup, Christian J; Nahrendorf, Matthias; Figueiredo, Jose Luiz et al. (2012) Painting blood vessels and atherosclerotic plaques with an adhesive drug depot. Proc Natl Acad Sci U S A 109:21444-9 |
Lu, Xin; Agasti, Sarit S; Vinegoni, Claudio et al. (2012) Optochemogenetics (OCG) allows more precise control of genetic engineering in mice with CreER regulators. Bioconjug Chem 23:1945-51 |
Hendricks, J Adam; Keliher, Edmund J; Wan, Dongpeng et al. (2012) Synthesis of [18F]BODIPY: bifunctional reporter for hybrid optical/positron emission tomography imaging. Angew Chem Int Ed Engl 51:4603-6 |
Showing the most recent 10 out of 44 publications